Breaking
ATDev closes $3M seed round led by Dobrzelecki Legacy Ventures Reflex knee-rehab robot weighs under 5 lbs - roughly 10x lighter than rivals Named SXSW Pitch 2026 finalist Subcontractor on $41M ARPA-H RAMMP mobility program FDA-listed since April 2024 Now shipping to VA hospitals and PT clinics ATDev closes $3M seed round led by Dobrzelecki Legacy Ventures Reflex knee-rehab robot weighs under 5 lbs - roughly 10x lighter than rivals Named SXSW Pitch 2026 finalist Subcontractor on $41M ARPA-H RAMMP mobility program FDA-listed since April 2024 Now shipping to VA hospitals and PT clinics
Company Dossier // Assistive Robotics Los Angeles, CA · Est. 2020

ATDev & the 5-Pound Physical Therapist

A UC Berkeley spinout building an ecosystem of robots that keep people independent - starting with a knee brace that does your rehab homework for you.

ATDev logo - Assistive Technology Development
The ATDev mark. A company whose whole thesis is that hardware should be light enough to lift, and quiet enough to trust. The logo, like the robot, doesn't shout.
The Pitch

A rehab robot with an unusually literal origin story

Here is a fact about startups that sounds made up but isn't: two of the co-founders of ATDev met because one of them answered the other's Craigslist ad looking for a roommate. That is the entire due-diligence process. No warm intro, no accelerator matchmaking - just Todd Roberts, an incoming Berkeley grad student, needing a place to live, and Owen Kent, a Berkeley film graduate and lifelong wheelchair user, needing rent.

The reason this matters, and the reason it's not just a cute anecdote, is that the company they eventually built is organized around exactly this kind of accident. ATDev - legally, Assistive Technology Development, Inc. - makes medical devices for people with limited mobility. Its design philosophy is summarized on the tin as "for users, by users," which is the sort of phrase that means nothing until you learn that one of the founders is himself paralyzed from the neck down. When Kent says a piece of assistive technology is annoying to use, this is not a hypothesis. It is a Tuesday.

The product that came out of this arrangement is called Reflex, and the elevator version is: it's a motorized knee brace that weighs less than five pounds and guides you through physical therapy at home. That's it. That's the robot. If you have had a knee replacement, you know that the hard part of recovery is not the surgery - it's the weeks afterward when you're supposed to do your exercises and you mostly don't, because they hurt and no one is watching. Reflex watches.

<5 lb
Reflex device weight
$3M
Seed round, Oct 2025
2020
Founded / Berkeley spinout
$41M
ARPA-H program (subcontractor)
The Mechanism

What the robot actually does

SUPPORT · RESIST · MEASURE · REPORT

The clever thing about Reflex is that it plays two roles depending on where you are in recovery, and it can switch between them. Early on, when your knee won't bend and every degree of motion is a negotiation, the device provides supportive force - it gently helps your leg move through its range. Later, when the problem is that your muscles have atrophied, it flips to resistive force, so that bending your knee becomes exercise. It is, in effect, a physical therapist who never gets tired of you and never double-books.

Built-in sensors track the three numbers that clinicians actually care about: your range of motion, your strength, and - the awkward one - your adherence. Are you doing the exercises? How many? The device knows, and it tells your care team wirelessly. This is the part that makes Reflex a telehealth product rather than a fancy brace. A clinician can look at your data from across the state, decide you're progressing faster than expected, and adjust your program remotely without you driving anywhere.

The design constraint that governs all of this is weight, which sounds boring and is actually the whole ballgame. ATDev says Reflex is nearly ten times lighter than other at-home assisted-therapy devices. If you are 72 and recovering from surgery, a therapy robot you cannot lift is not a therapy robot. It is furniture. Making the thing light enough to strap on without help is the difference between a device people use and a device people resent.

Flagship product

Reflex

A telehealth-enabled robotic knee brace under 5 lbs. Guides personalized stretching and strengthening, senses range of motion / strength / adherence, and streams it to clinicians. FDA-listed since April 2024; limited US launch across 10 states in 2025.

Research platform

RAMMP

The Robotic Assistive Mobility and Manipulation Platform - next-generation intelligent wheelchair tech with robotic arms, cameras, and autonomous navigation. Built open-source as a subcontractor on a $41M, five-year ARPA-H program led by the University of Pittsburgh.

"Creating this ecosystem of robotic devices that enable people to stay independent."

- TODD ROBERTS, CEO & CO-FOUNDER, ON THE COMPANY'S BROADER MISSION
The Unusual Part

A hardware company that keeps giving things away

Most medical-device companies treat their intellectual property the way dragons treat gold. ATDev is doing something stranger: the mobility platform it's building through the federal RAMMP program is open-source. The idea, roughly, is that if you want to reinvent the wheelchair for the 21st century - robotic arms, cameras, software that can drive itself across a kitchen - you should not make every research group start from scratch behind a patent wall. So they're building it in the open, alongside a consortium of five universities and three companies, on ARPA-H's dime.

There's a demographic engine behind all of this that's worth stating plainly. More than 61 million Americans live with a disability. Roughly 10,000 Americans turn 65 every single day. The market for "help people stay mobile and independent" is not a niche; it is a slow-motion tidal wave, and most of the incumbents still assume you'll come to a clinic. ATDev's bet is that the clinic should come to you, in progressively lighter and smarter packages.

The company's funding history is its own kind of tell. This is not a blitzscaling story. It's a $3,000 class grant, then a $50,000 NSF I-Corps grant, then $200,000 from Berkeley SkyDeck, then - six years after the first sketch - a $3 million seed round. Patient capital for a patient problem. You do not rush an FDA listing, and ATDev didn't.

The originReflex was pitched in a Berkeley biomechanics class, "Designing for the Human Body."
The co-founderOwen Kent is a lifelong wheelchair user and a film major - not an engineer.
The reachAlready shipping to Veterans Affairs hospitals and private PT clinics.
The roadmapFuture targets: stroke recovery and neuromuscular rehabilitation.
Who It's For

What you can actually do with it

If you're a patient recovering from knee surgery, Reflex is prescribed and fitted for you, delivered to your home, and used on your own schedule - with the reassurance that your physical therapist can see whether it's working. If you're a clinic or a physical therapist, it's a way to extend your reach past the four walls of your practice and keep tabs on patients who would otherwise vanish the moment they leave. If you're a health system - and Veterans Affairs hospitals are early adopters here - it's a way to deliver consistent rehab to people who can't easily travel for it.

And if you're a researcher or an engineer in the assistive-tech world, ATDev's second act - the open-source RAMMP platform - is something you can actually build on rather than just admire from outside. That's an unusual thing to be able to say about a for-profit medical-device startup, and it's the clearest signal of where the company thinks it's going: not one product, but an ecosystem.

Milestones

2020
Concept pitched in a UC Berkeley biomechanics course; $3,000 prototype grant from the Jacobs Institute. Company spins out.
2021
$50,000 NSF I-Corps grant funds 100+ customer interviews.
2022
Berkeley SkyDeck invests $200,000 - first venture funding.
APR 2024
Reflex becomes FDA-listed.
2025
Limited US launch across 10 states; joins the $41M ARPA-H RAMMP program as a subcontractor.
OCT 2025
Closes $3M seed round led by Dobrzelecki Legacy Ventures.
2026
Named a SXSW Pitch 2026 finalist.
Follow The Money

The cap table, briefly

RoundAmountDateBackers
Seed$3,000,000Oct 2025Dobrzelecki Legacy Ventures (lead), Uphonest Capital, The Life Science Angels
Accelerator$200,0002022Berkeley SkyDeck
Grant (NSF I-Corps)$50,0002021National Science Foundation
Grant (prototype)$3,0002020Jacobs Institute for Design Innovation

Total disclosed funding sits around $3 million, with roughly 12 people on the team. The competitive neighborhood includes connected-rehab and motion-therapy players like Hinge Health, Sword Health, and ROMTech, plus the oldest competitor of all: driving to a clinic and doing it in person. ATDev's wedge is the hardware - a device light and smart enough to make the in-person version feel optional.

"If they're passionate about something, they can spin it up and make an impact - just don't expect it to happen overnight."

- TODD ROBERTS, ON A SIX-YEAR JOURNEY FROM CLASSROOM TO MARKET

Quick facts: ATDev

ATDev (Assistive Technology Development, Inc.) is a UC Berkeley spinout building an ecosystem of robotic devices that help people stay independent. Its flagship product, Reflex, is a smart, under-5-pound robotic knee brace that delivers personalized, telehealth-enabled physical therapy at home and streams progress data back to clinicians. Founded by engineer Todd Roberts and disability-rights advocate Owen Kent, the company designs 'for users, by users' and is scaling after a $3M seed round while also serving as a subcontractor on a $41M ARPA-H robotic mobility program.

Founded
2020
Headquarters
Los Angeles / Orange, California, United States
Founders
Todd Roberts (CEO & Co-Founder), Owen Kent (Co-Founder (CMO / Chief Medical Officer))
Team size
~12 employees
Products
Reflex, RAMMP (Robotic Assistive Mobility and Manipulation Platform)
Notable
FDA-listed device (Reflex), April 2024, Raised $3M seed round in October 2025, Selected as SXSW Pitch 2026 finalist

Last updated: